These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 12652385)

  • 1. Ocular and respiratory symptoms attributable to inactivated split influenza vaccine: evidence from a controlled trial involving adults.
    Scheifele DW; Duval B; Russell ML; Warrington R; DeSerres G; Skowronski DM; Dionne M; Kellner J; Davies D; MacDonald J
    Clin Infect Dis; 2003 Apr; 36(7):850-7. PubMed ID: 12652385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, double-blind, placebo-controlled trial to assess the rate of recurrence of oculorespiratory syndrome following influenza vaccination among persons previously affected.
    Skowronski DM; De Serres G; Scheifele D; Russell ML; Warrington R; Davies HD; Dionne M; Duval B; Kellner J; MacDonald J
    Clin Infect Dis; 2003 Oct; 37(8):1059-66. PubMed ID: 14523770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrence risk of oculorespiratory syndrome after influenza vaccination: randomized controlled trial of previously affected persons.
    De Serres G; Skowronski DM; Guay M; Rochette L; Jacobsen K; Fuller T; Duval B
    Arch Intern Med; 2004 Nov; 164(20):2266-72. PubMed ID: 15534165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza vaccination in adults with asthma: safety of an inactivated trivalent influenza vaccine.
    Kmiecik T; Arnoux S; Kobryn A; Gorski P
    J Asthma; 2007 Dec; 44(10):817-22. PubMed ID: 18097856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Side effects associated with influenza vaccination in healthy working adults. A randomized, placebo-controlled trial.
    Nichol KL; Margolis KL; Lind A; Murdoch M; McFadden R; Hauge M; Magnan S; Drake M
    Arch Intern Med; 1996 Jul; 156(14):1546-50. PubMed ID: 8687262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does antigen-specific cytokine response correlate with the experience of oculorespiratory syndrome after influenza vaccine?
    Skowronski DM; Lu H; Warrington R; Hegele RG; De Serres G; HayGlass K; Stark D; White R; Macnabb J; Li Y; Manson HE; Brunham RC
    J Infect Dis; 2003 Feb; 187(3):495-9. PubMed ID: 12552434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity, safety, and cross-reactivity of an inactivated, adjuvanted, prototype pandemic influenza (H5N1) vaccine: a phase II, double-blind, randomized trial.
    Wu J; Fang HH; Chen JT; Zhou JC; Feng ZJ; Li CG; Qiu YZ; Liu Y; Lu M; Liu LY; Dong SS; Gao Q; Zhang XM; Wang N; Yin WD; Dong XP
    Clin Infect Dis; 2009 Apr; 48(8):1087-95. PubMed ID: 19281330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of inactivated split-virus influenza vaccine against culture-confirmed influenza in healthy adults: a prospective, randomized, placebo-controlled trial.
    Beran J; Vesikari T; Wertzova V; Karvonen A; Honegr K; Lindblad N; Van Belle P; Peeters M; Innis BL; Devaster JM
    J Infect Dis; 2009 Dec; 200(12):1861-9. PubMed ID: 19909082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oculo-respiratory syndrome: a new influenza vaccine-associated adverse event?
    Skowronski DM; Strauss B; De Serres G; MacDonald D; Marion SA; Naus M; Patrick DM; Kendall P
    Clin Infect Dis; 2003 Mar; 36(6):705-13. PubMed ID: 12627354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical data on Fluarix: an inactivated split seasonal influenza vaccine.
    El Sahly HM; Keitel WA
    Expert Rev Vaccines; 2008 Aug; 7(6):713-9. PubMed ID: 18665769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oculo-respiratory syndrome after influenza vaccination: trends over four influenza seasons.
    De Serres G; Toth E; Ménard S; Grenier JL; Roussel R; Tremblay M; Landry M; Robert Y; Rochette L; Skowronski DM
    Vaccine; 2005 May; 23(28):3726-32. PubMed ID: 15882534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety and immunogenicity of influenza vaccine in children with asthma in Mexico.
    Pedroza A; Huerta JG; Garcia Mde L; Rojas A; López-Martínez I; Penagos M; Franco-Paredes C; Deroche C; Mascareñas C
    Int J Infect Dis; 2009 Jul; 13(4):469-75. PubMed ID: 19084453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with inactivated, virosomal influenza vaccine.
    de Bruijn IA; Nauta J; Cramer WC; Gerez L; Palache AM
    Vaccine; 2005 Jul; 23 Suppl 1():S39-49. PubMed ID: 16005120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults.
    Treanor JJ; Schiff GM; Couch RB; Cate TR; Brady RC; Hay CM; Wolff M; She D; Cox MM
    J Infect Dis; 2006 May; 193(9):1223-8. PubMed ID: 16586358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and immunogenicity of a Proteosome -trivalent inactivated influenza vaccine, given nasally to healthy adults.
    Langley JM; Halperin SA; McNeil S; Smith B; Jones T; Burt D; Mallett CP; Lowell GH; Fries L
    Vaccine; 2006 Mar; 24(10):1601-8. PubMed ID: 16303215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial.
    Holland D; Booy R; De Looze F; Eizenberg P; McDonald J; Karrasch J; McKeirnan M; Salem H; Mills G; Reid J; Weber F; Saville M
    J Infect Dis; 2008 Sep; 198(5):650-8. PubMed ID: 18652550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ophthalmological and biological features of the oculorespiratory syndrome after influenza vaccination.
    Fredette MJ; De Serres G; Malenfant M
    Clin Infect Dis; 2003 Oct; 37(8):1136-8. PubMed ID: 14523781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study on safety and immunogenicity between influenza subunit vaccine and split vaccine].
    Dong PM; Li YQ; Zheng TZ; Jia YP; Li F; Han TW; Qiao RX; Zhang BH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul; 24(7):570-3. PubMed ID: 12975010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza vaccine oculorespiratory syndrome incidence is reduced in HIV.
    Cooper C; Thorne A;
    Vaccine; 2011 Oct; 29(45):7876-7. PubMed ID: 21872629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse effects associated with influenza vaccination in patients with COPD: a randomized controlled study.
    Wongsurakiat P; Maranetra KN; Gulprasutdilog P; Aksornint M; Srilum W; Ruengjam C; Sated W
    Respirology; 2004 Nov; 9(4):550-6. PubMed ID: 15612969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.